Friday, 22 April 2022

Lupin Receives Tentative Approval from U.S. FDA for Tenofovir Alafenamide Tablets

Lupin Receives Tentative Approval from U.S. FDA for Tenofovir Alafenamide Tablets
Lupin Receives Tentative Approval from USFDA for Tenofovir Alafenamide Tablets

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

admin Fri, 04/22/2022 - 15:38

source https://www.pharmatutor.org/pharma-news/2022/lupin-receives-tentative-approval-from-usfda-for-tenofovir-alafenamide-tablets

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...